Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma
British Journal of Haematology · 2026-06 · 208 (6) · 2326-2326
DOI: 10.1111/bjh.70522 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 07.05.2026. Verfasst von Can Yan und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Autor:innen und Institutionen
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University, Shenzhen, Guangdong, China.
ORCID-Profile: Jinlin Liu
Zitieren
APA
Yan, C., & Liu, J. (2026). Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma. British Journal of Haematology, 208(6), 2326-2326. https://doi.org/10.1111/bjh.70522
Vancouver
Yan C, Liu J. Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma. British Journal of Haematology. 2026;208(6):2326-2326. doi:10.1111/bjh.70522
BibTeX
@article{Yan2026,
author = {Yan, Can and Liu, Jinlin},
title = {Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {2326--2326},
doi = {10.1111/bjh.70522}
}
EUVIMED